- Home
- BMRN vs LEVI Comparison
BMRN vs LEVI Comparison
Compare BMRN & LEVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BMRN | LEVI |
|---|---|---|
| Founded | 1996 | 1853 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.0B | 9.1B |
| IPO Year | 1999 | 2019 |
Fundamental Metrics
Financial Performance| Metric | BMRN | LEVI |
|---|---|---|
| Price | $59.05 | $18.09 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 13 |
| Target Price | ★ $87.24 | $26.31 |
| AVG Volume (30 Days) | ★ 2.1M | 2.1M |
| Earning Date | 05-21-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 3.06% |
| EPS Growth | N/A | ★ 178.85 |
| EPS | ★ 1.80 | 1.45 |
| Revenue | $1,313,646,000.00 | ★ $6,282,000,000.00 |
| Revenue This Year | $13.34 | $7.85 |
| Revenue Next Year | $11.42 | $4.92 |
| P/E Ratio | $33.51 | ★ $12.62 |
| Revenue Growth | ★ 17.62 | N/A |
| 52 Week Low | $50.76 | $12.17 |
| 52 Week High | $73.18 | $24.82 |
Technical Indicators
Market Signals| Indicator | BMRN | LEVI |
|---|---|---|
| Relative Strength Index (RSI) | 47.81 | 27.09 |
| Support Level | $56.08 | $16.64 |
| Resistance Level | $60.52 | $22.51 |
| Average True Range (ATR) | 2.28 | 0.62 |
| MACD | -0.28 | -0.42 |
| Stochastic Oscillator | 15.11 | 7.55 |
Price Performance
Historical ComparisonAbout BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
About LEVI Levi Strauss & Co
Levi Strauss & Co is involved in designing, marketing, and selling products that include jeans, casual and dresses pants, tops, shorts, skirts, jackets, footwear, and related accessories directly or through third parties and licensees for men, women, and children under Levi's, Dockers, Signature by Levi Strauss & Co. and Denizen brands. The company manages its business according to three regional segments: the Americas, which is the key revenue driver; Europe; and Asia.